Randomized Trials or Population-based Registries

European Journal of Vascular and Endovascular Surgery

Volumn 34, Issue 3, 2007, Pages 253-256

  Bergqvist, D ^a   Bjorck M ^a   Sawe J ^b   Troeng T ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Council on Technology Assessment in Health Care   (Sweden)

^c BLEKINGE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

CAROTID ARTERY ANEURYSM; CAROTID ENDARTERECTOMY; CASE CONTROL STUDY; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE REGISTRY; EDITORIAL; EFFECT SIZE; ENDOVASCULAR SURGERY; EXTERNAL VALIDITY; HEART INFARCTION; HUMAN; INTERNAL VALIDITY; METHODOLOGY; OBSERVATIONAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION;

EID: 34547604467     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.06.014     Document Type: Editorial

References (23)

1. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 317 3 (1987) 141-145
2. Peto R., and Baigent C. Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ 317 7167 (1998) 1170-1171
3. Fleming T.R., and DeMets D.L. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 125 7 (1996) 605-613
4. Rosen M. On randomized controlled trials and lifestyle interventions. Int J Epidemiol 18 4 (1989) 993-994
5. Lindholm L., and Rosen M. What is the "golden standard" for assessing population-based interventions?-problems of dilution bias. J Epidemiol Community Health 54 8 (2000) 617-622
6. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 8 (1996) 637-639
7. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9263 (2001) 1191-1194
8. Egger M., Juni P., and Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA 285 15 (2001) 1996-1999
9. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., and Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328 20 (1993) 1450-1456
10. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., and Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328 20 (1993) 1444-1449
11. Hodis H.N., Mack W.J., LaBree L., Cashin-Hemphill L., Sevanian A., Johnson R., and Azen S.P. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273 23 (1995) 1849-1854
12. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 3 (2000) 145-153
13. Stevens R.D., Burri H., and Tramer M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97 3 (2003) 623-633
14. Auerbach A.D., and Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 287 11 (2002) 1435-1444
15. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 24 (1999) 1789-1794
16. Redelmeier D., Scales D., and Kopp A. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ 331 7522 (2005) 932
17. Thomas S.M., Beard J.D., Ireland M., and Ayers S. Results from the prospective registry of endovascular treatment of abdominal aortic aneurysms (RETA): mid term results to five years. Eur J Vasc Endovasc Surg 29 6 (2005) 563-570
18. Greenhalgh R.M., Brown L.C., Kwong G.P., Powell J.T., and Thompson S.G. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364 9437 (2004) 843-848
19. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365 9478 (2005) 2179-2186
20. Prinssen M., Verhoeven E.L., Buth J., Cuypers T.W.M., Sambeek M.R.H.M., Balm R., et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351 16 (2004) 1607-1618
21. Kragsterman B., Pärsson H., Bergqvist D., and Björck M. Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving-results from a population based registry. J Vasc Surg 44 (2006) 79-85
22. Grol R., and Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 362 9391 (2003) 1225-1230
23. Prytherch D.R., Ridler B.M., Beard J.D., Earnshaw J.J., and Audit and Research Committee. The Vascular Society of Great Britain and Ireland. A model for national outcome audit in vascular surgery. Eur J Vasc Endovasc Surg 21 6 (2001) 477-483